Trading window closed from July 1 till Q1 results declaration

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.4%Reaction day

₹0.29

prior close

₹0.28

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%+3.7% vs market

Trading & Distributors peers, median of 132sector-0.7%+4.2% vs sector

On the reaction day the stock moved 3.7 pts more than Nifty Microcap 250 and 4.2 pts more than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.4-0.3+3.7-0.7+4.2

Next day

+6.9+0.8+6.1-0.4+7.3

+6.9+0.9+6.0-0.9+7.8

+6.9+1.8+5.1-0.9+7.8

+10.3+1.5+8.9-0.8+11.1

+13.8+1.7+12.1-1.1+14.9

+17.2-1.1+18.3-2.7+20.0

15d

+10.3+1.0+9.3-3.6+14.0

+13.8+0.4+13.4-3.5+17.3

+3.4+6.4-2.9-4.7+8.2

-10.3+5.5-15.8-4.4-5.9

UpDownMarket · Nifty Microcap 250Sector · Trading & Distributors peers, median of 132Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Supha Pharmachem has closed its trading window from Wednesday, 1 July 2026 until 48 hours after declaring Q1 financial results for the quarter ended 30 June 2026. This is a routine SEBI insider trading compliance step before results. The company, formerly Remedium Lifecare, is currently under CIRP (insolvency resolution), with Mr. Raju Mangilal Marshiya as Resolution Professional.

Likely market impact

Routine compliance ahead of quarterly results. Designated persons cannot trade in this period. No direct price impact expected.